Andexanet alfa (ONDEXXYA ® for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence
Yajima, Toshitaka, Higashimori, Mitsuo, Takata, Chie, Sasabe, Toshikazu
Published in Nihon yakurigaku zasshi (2023)
Published in Nihon yakurigaku zasshi (2023)
Get more information
Journal Article
Pharmacological and clinical profile of asciminib hydrochloride, a novel first-in-class tyrosine kinase inhibitor specifically targeting ABL myristoyl pocket
Chung, Jihye, Ariyoshi, Taisuke, Yoneda, Tomohiro, Kagawa, Yusuke, Kawakita, Yasunori, Maki, Akio
Published in Nihon yakurigaku zasshi (2023)
Published in Nihon yakurigaku zasshi (2023)
Get more information
Journal Article
Pharmacological and clinical profile of Onasemnogene Aveparvovec, the first gene therapy for spinal muscular atrophy (SMA)
Atsumi, Ayaka, Yoneda, Tomohiro, Tsuchida, Ken, Kagawa, Yusuke, Tominaga, Shunsuke, Kawase, Kazuho, Kikuchi, Nobutaka
Published in Nihon yakurigaku zasshi (2022)
Published in Nihon yakurigaku zasshi (2022)
Get more information
Journal Article